TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $8,700,000 | -23.9% | 78,727 | +0.3% | 2.01% | -27.9% |
| Q2 2016 | $11,425,000 | +7.9% | 78,468 | +6.1% | 2.79% | -3.0% |
| Q1 2016 | $10,590,000 | -7.8% | 73,926 | -0.6% | 2.87% | -0.2% |
| Q4 2015 | $11,490,000 | +31.4% | 74,343 | +19.2% | 2.88% | +23.7% |
| Q3 2015 | $8,745,000 | +16.5% | 62,387 | +15.2% | 2.33% | -12.0% |
| Q2 2015 | $7,505,000 | -4.8% | 54,134 | -3.1% | 2.64% | -14.3% |
| Q1 2015 | $7,880,000 | -3.6% | 55,873 | +1.3% | 3.08% | -8.0% |
| Q4 2014 | $8,177,000 | +8.1% | 55,178 | +12.3% | 3.36% | +12.6% |
| Q3 2014 | $7,561,000 | +198.6% | 49,142 | +172.1% | 2.98% | +171.9% |
| Q2 2014 | $2,532,000 | -0.4% | 18,058 | -21.1% | 1.10% | +6.3% |
| Q1 2014 | $2,541,000 | +12.5% | 22,891 | +0.3% | 1.03% | +4.2% |
| Q4 2013 | $2,258,000 | +16.2% | 22,828 | -10.7% | 0.99% | +7.5% |
| Q3 2013 | $1,943,000 | +10.0% | 25,563 | -19.1% | 0.92% | +0.8% |
| Q2 2013 | $1,766,000 | – | 31,590 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |